drugset / Trial / NCT02538432
Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a phase II trial of (RQ-07) in advanced solid tumors in prostate, breast or non-small cell lung cancer.
Timeline
- Start
- 2017-06
- Primary completion
- 2019-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |
| Subject | grapiprant | Small molecule | 250 mg | Oral |